Healing Diabetic Foot Ulcers: A Comparative Review of Debridement Approaches
DOI:
https://doi.org/10.12775/QS.2024.21.44262Keywords
diabetic foot treatment, diabetic foot ulcers (DFU), autolytic debridement, healing DFUAbstract
Introduction and objective: More than 400 million people worldwide suffer from diabetes today. As a result of complications of this disease, diabetic foot ulcers (DFU) develop. Wound treatment consists mainly in cleansing and stimulating tissue healing processes. Depending on the method used, this process may be shorter or longer.
Review methods: In March 2023, articles found in the Medline (Pubmed) and Google Scholar databases were selected by using the following keywords: diabetic foot treatment, diabetic foot ulcers (DFU), autolytic debridement, healing DFU.
Brief description of the state of knowledge: Each of the methods described in this article has its advantages and disadvantages. Surgical debridement is used in wounds with a large amount of necrotic tissue, but it can be associated with great discomfort for the patient. Clostridial collagenase ointment has been found to be effective in reducing wound area and promoting wound closure but is more expensive. The use of autolytic debridement and larval therapy is associated with a reduction in pro-inflammatory markers, while the use of moist dressings provides a suitable environment for tissue regeneration.
Summary: The choice of the appropriate method depends on many factors such as: the patient's condition, the availability of materials and financial resources. This review paper provides a comprehensive overview of the benefits and drawbacks of different debridement methods for diabetic foot ulcers.
References
[1] J. Deng, M. Yang, X. Zhang, and H. Zhang, “Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcer healing: a systematic review and meta-analysis of randomized controlled trials,” J Orthop Surg Res, vol. 18, no. 1, p. 370, May 2023, doi: 10.1186/S13018-023-03854-X.
[2] A. S. Rayate, B. S. Nagoba, S. S. Mumbre, H. B. Mavani, A. M. Gavkare, and A. S. Deshpande, “Current scenario of traditional medicines in management of diabetic foot ulcers: A review,” World J Diabetes, vol. 14, no. 1, p. 1, Jan. 2023, doi: 10.4239/WJD.V14.I1.1.
[3] G. J. Vazquez-Zapien et al., “Skin wound healing improvement in diabetic mice through FTIR microspectroscopy after implanting pluripotent stem cells,” APL Bioeng, vol. 7, no. 1, p. 16109, Mar. 2023, doi: 10.1063/5.0130383.
[4] F. Niami et al., “Evaluation of the effect of a gel made with amniotic fluid formulation on the healing of diabetic foot ulcers: A triple-blind clinical trial,” Front Public Health, vol. 10, Dec. 2022, doi: 10.3389/FPUBH.2022.1025391.
[5] Y. Wang et al., “Risk factors for diabetic foot ulcers mortality and novel negative pressure combined with platelet-rich plasma therapy in the treatment of diabetic foot ulcers,” Front Pharmacol, vol. 13, Dec. 2022, doi: 10.3389/FPHAR.2022.1051299.
[6] A. Tallis, T. A. Motley, R. P. Wunderlich, J. E. Dickerson, C. Waycaster, and H. B. Slade, “Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study,” Clin Ther, vol. 35, no. 11, pp. 1805–1820, Nov. 2013, doi: 10.1016/J.CLINTHERA.2013.09.013.
[7] T. R. Bellomo et al., “Management of the diabetic foot,” Semin Vasc Surg, vol. 35, no. 2, pp. 219–227, Jun. 2022, doi: 10.1053/J.SEMVASCSURG.2022.04.002.
[8] E. Everett and N. Mathioudakis, “Update on management of diabetic foot ulcers,” Ann N Y Acad Sci, vol. 1411, no. 1, pp. 153–165, Jan. 2018, doi: 10.1111/NYAS.13569.
[9] T. Elraiyah et al., “A systematic review and meta-analysis of débridement methods for chronic diabetic foot ulcers,” J Vasc Surg, vol. 63, no. 2 Suppl, pp. 37S-45S.e2, Feb. 2016, doi: 10.1016/J.JVS.2015.10.002.
[10] E. Sukur et al., “Vacuum-assisted closure versus moist dressings in the treatment of diabetic wound ulcers after partial foot amputation: A retrospective analysis in 65 patients,” J Orthop Surg (Hong Kong), vol. 26, no. 3, Sep. 2018, doi: 10.1177/2309499018799769.
[11] D. Seidel et al., “Negative pressure wound therapy compared with standard moist wound care on diabetic foot ulcers in real-life clinical practice: results of the German DiaFu-RCT,” BMJ Open, vol. 10, no. 3, Mar. 2020, doi: 10.1136/BMJOPEN-2018-026345.
[12] A. Tallis, T. A. Motley, R. P. Wunderlich, J. E. Dickerson, C. Waycaster, and H. B. Slade, “Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study,” Clin Ther, vol. 35, no. 11, pp. 1805–1820, Nov. 2013, doi: 10.1016/J.CLINTHERA.2013.09.013.
[13] D. Dayya, O. J. O’Neill, T. B. Huedo-Medina, N. Habib, J. Moore, and K. Iyer, “Debridement of Diabetic Foot Ulcers,” Adv Wound Care (New Rochelle), vol. 11, no. 12, pp. 666–686, Dec. 2022, doi: 10.1089/WOUND.2021.0016.
[14] “Wound Debridement - StatPearls - NCBI Bookshelf.” https://www.ncbi.nlm.nih.gov/books/NBK507882/#_NBK507882_pubdet_ (accessed May 13, 2023).
[15] L. Michailidis, S. M. Bergin, T. P. Haines, and C. M. Williams, “Healing rates in diabetes-related foot ulcers using low frequency ultrasonic debridement versus non-surgical sharps debridement: a randomised controlled trial,” BMC Res Notes, vol. 11, no. 1, Oct. 2018, doi: 10.1186/S13104-018-3841-4.
[16] N. Parizad, K. Hajimohammadi, and R. Goli, “Surgical debridement, maggot therapy, negative pressure wound therapy, and silver foam dressing revive hope for patients with diabetic foot ulcer: A case report,” Int J Surg Case Rep, vol. 82, May 2021, doi: 10.1016/J.IJSCR.2021.105931.
[17] N. Parizad, K. Hajimohammadi, R. Goli, Y. Mohammadpour, N. Faraji, and K. Makhdomi, “Surgical debridement and maggot debridement therapy (MDT) bring the light of hope to patients with diabetic foot ulcers (DFUs): A case report,” Int J Surg Case Rep, vol. 99, Oct. 2022, doi: 10.1016/J.IJSCR.2022.107723.
[18] J. E. Dickerson, “Enzymatic Debridement of Chronic Nonischemic Diabetic Foot Ulcers,” 2018, pp. 213–220. doi: 10.1007/15695_2018_118.
[19] T. A. Motley, J. M. Caporusso, D. L. Lange, R. A. Eichelkraut, D. I. Cargill, and J. E. Dickerson, “Clinical Outcomes for Diabetic Foot Ulcers Treated with Clostridial Collagenase Ointment or with a Product Containing Silver,” Adv Wound Care (New Rochelle), vol. 7, no. 10, pp. 339–348, Oct. 2018, doi: 10.1089/WOUND.2018.0784.
[20] C. Waycaster, M. J. Carter, A. M. Gilligan, E. S. Mearns, C. E. Fife, and C. T. Milne, “Comparative cost and clinical effectiveness of clostridial collagenase ointment for chronic dermal ulcers,” J Comp Eff Res, vol. 7, no. 2, pp. 149–165, Feb. 2018, doi: 10.2217/CER-2017-0066.
[21] C. T. Milne, A. O. Ciccarelli, and M. Lassy, “A comparison of collagenase to hydrogel dressings in wound debridement,” Wounds, vol. 22, no. 11, pp. 270–274, Nov. 2010, Accessed: May 15, 2023. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/25901516/
[22] R. C. Galperin et al., “Anti-inflammatory Effects of Clostridial Collagenase Results from In Vitro and Clinical Studies,” J Am Podiatr Med Assoc, vol. 105, no. 6, pp. 509–519, 2015, doi: 10.7547/14-066.1.
[23] K. Opletalová et al., “Maggot Therapy for Wound Debridement: A Randomized Multicenter Trial,” Arch Dermatol, vol. 148, no. 4, pp. 432–438, Apr. 2012, doi: 10.1001/ARCHDERMATOL.2011.1895.
[24] M. Z. M. Zubir, S. Holloway, and N. M. Noor, “Maggot Therapy in Wound Healing: A Systematic Review.,” Int J Environ Res Public Health, vol. 17, no. 17, pp. E6103–E6103, Aug. 2020, doi: 10.3390/IJERPH17176103.
[25] H. K. R. Nair et al., “Maggot debridement therapy to treat hard-to-heal diabetic foot ulcers: a single-centre study,” J Wound Care, vol. 30, no. Sup12, pp. S30–S36, Dec. 2021, doi: 10.12968/JOWC.2021.30.SUP12.S30.
[26] M. Gieroń, M. Słowik-Rylska, and B. Kręcisz, “Effectiveness of maggot debridement therapy in treating chronic wounds – review of current literature,” Medical Studies/Studia Medyczne, vol. 34, no. 4, pp. 325–331, 2018, doi: 10.5114/MS.2018.80949.
[27] A. Malekian et al., “Efficacy of Maggot Therapy on Staphylococcus aureus and Pseudomonas aeruginosa in Diabetic Foot Ulcers: A Randomized Controlled Trial,” Journal of Wound, Ostomy and Continence Nursing, vol. 46, no. 1, pp. 25–29, Jan. 2019, doi: 10.1097/WON.0000000000000496.
[28] M. Eneroth and W. H. van Houtum, “The value of debridement and Vacuum-Assisted Closure (V.A.C.) Therapy in diabetic foot ulcers,” Diabetes Metab Res Rev, vol. 24, no. S1, pp. S76–S80, May 2008, doi: 10.1002/dmrr.852.
[29] H. J. Degreef, “HOW TO HEAL A WOUND FAST,” Dermatol Clin, vol. 16, no. 2, pp. 365–375, Apr. 1998, doi: 10.1016/S0733-8635(05)70019-X.
[30] M. Barbosa, V. Carvalho, and A. Paggiaro, “Hydrogel Enriched With Sodium Alginate and Vitamins A and E for Diabetic Foot Ulcer: A Randomized Controlled Trial,” Wounds, vol. 34, no. 9, pp. 229–235, 2022, doi: 10.25270/wnds/20103.
[31] T. Elraiyah et al., “A systematic review and meta-analysis of débridement methods for chronic diabetic foot ulcers,” J Vasc Surg, vol. 63, no. 2, pp. 37S-45S.e2, Feb. 2016, doi: 10.1016/j.jvs.2015.10.002.
[32] J. C. Dumville, S. O’Meara, S. Deshpande, and K. Speak, “Hydrogel dressings for healing diabetic foot ulcers,” in Cochrane Database of Systematic Reviews, J. C. Dumville, Ed., Chichester, UK: John Wiley & Sons, Ltd, 2011. doi: 10.1002/14651858.CD009101.pub2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anna Brzyska, Kamila Mozga, Agnieszka Karabin, Małgorzata Bojarska, Natalia Domańska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 91
Number of citations: 0
